» Articles » PMID: 37670018

Retinal Inflammation in Murine Models of Type 1 and Type 2 Diabetes with Diabetic Retinopathy

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2023 Sep 5
PMID 37670018
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/hypothesis: The loss of pericytes surrounding the retinal vasculature in early diabetic retinopathy underlies changes to the neurovascular unit that lead to more destructive forms of the disease. However, it is unclear which changes lead to loss of retinal pericytes. This study investigated the hypothesis that chronic increases in one or more inflammatory factors mitigate the signalling pathways needed for pericyte survival.

Methods: Loss of pericytes and levels of inflammatory markers at the mRNA and protein levels were investigated in two genetic models of diabetes, Ins2 (a model of type 1 diabetes) and Lepr (a model of type 2 diabetes), at early stages of diabetic retinopathy. In addition, changes that accompany gliosis and the retinal vasculature were determined. Finally, changes in retinal pericytes chronically incubated with vehicle or increasing amounts of IFNγ were investigated to determine the effects on pericyte survival. The numbers of pericytes, microglia, astrocytes and endothelial cells in retinal flatmounts were determined by immunofluorescence. Protein and mRNA levels of inflammatory factors were determined using multiplex ELISAs and quantitative reverse transcription PCR (qRT-PCR). The effects of IFNγ on the murine retinal pericyte survival-related platelet-derived growth factor receptor β (PDGFRβ) signalling pathway were investigated by western blot analysis. Finally, the levels of cell death-associated protein kinase C isoform delta (PKCδ) and cleaved caspase 3 (CC3) in pericytes were determined by western blot analysis and immunocytochemistry.

Results: The essential findings of this study were that both type 1 and 2 diabetes were accompanied by a similar progression of retinal pericyte loss, as well as gliosis. However, inflammatory factor expression was dissimilar in the two models of diabetes, with peak expression occurring at different ages for each model. Retinal vascular changes were more severe in the type 2 diabetes model. Chronic incubation of murine retinal pericytes with IFNγ decreased PDGFRβ signalling and increased the levels of active PKCδ and CC3.

Conclusions/interpretation: We conclude that retinal inflammation is involved in and sustains pericyte loss as diabetic retinopathy progresses. Moreover, IFNγ plays a critical role in reducing pericyte survival in the retina by reducing activation of the PDGFRβ signalling pathway and increasing PKCδ levels and pericyte apoptosis.

Citing Articles

Vitamin D and Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Implications-A Narrative Review.

Fuentes-Barria H, Aguilera-Eguia R, Flores-Fernandez C, Angarita-Davila L, Rojas-Gomez D, Alarcon-Rivera M Int J Mol Sci. 2025; 26(5).

PMID: 40076782 PMC: 11900948. DOI: 10.3390/ijms26052153.


Retinal Müller Cell-Released Exosomal MiR-92a-3p Delivers Interleukin-17A Signal by Targeting Notch-1 to Promote Diabetic Retinopathy.

Qiu A, Wang N, Yin W, Zhu Z, Liu Q, Zhang W Invest Ophthalmol Vis Sci. 2025; 66(1):1.

PMID: 39745681 PMC: 11702826. DOI: 10.1167/iovs.66.1.1.


Traversing the epigenetic landscape: DNA methylation from retina to brain in development and disease.

Xu C, Fu X, Qin H, Yao K Front Cell Neurosci. 2024; 18:1499719.

PMID: 39678047 PMC: 11637887. DOI: 10.3389/fncel.2024.1499719.


Arylphthalide Delays Diabetic Retinopathy via Immunomodulating the Early Inflammatory Response in an Animal Model of Type 1 Diabetes Mellitus.

Martin-Loro F, Cano-Cano F, Ortega M, Cuevas B, Gomez-Jaramillo L, Gonzalez-Montelongo M Int J Mol Sci. 2024; 25(15).

PMID: 39126007 PMC: 11313200. DOI: 10.3390/ijms25158440.


Are Hyperglycemia-Induced Changes in the Retina Associated with Diabetes-Correlated Changes in the Brain? A Review from Zebrafish and Rodent Type 2 Diabetes Models.

Augustine-Wofford K, Connaughton V, McCarthy E Biology (Basel). 2024; 13(7).

PMID: 39056672 PMC: 11273949. DOI: 10.3390/biology13070477.

References
1.
Hammes H, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C . Pericytes and the pathogenesis of diabetic retinopathy. Diabetes. 2002; 51(10):3107-12. DOI: 10.2337/diabetes.51.10.3107. View

2.
Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, Marette A . Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med. 2009; 15(11):1298-306. PMC: 3290906. DOI: 10.1038/nm.2052. View

3.
Tang L, Xu G, Zhang J . Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy. Neural Regen Res. 2022; 18(5):976-982. PMC: 9827774. DOI: 10.4103/1673-5374.355743. View

4.
Rashid K, Akhtar-Schaefer I, Langmann T . Microglia in Retinal Degeneration. Front Immunol. 2019; 10:1975. PMC: 6710350. DOI: 10.3389/fimmu.2019.01975. View

5.
Dharmarajan S, Fisk D, Sorenson C, Sheibani N, Belecky-Adams T . Microglia activation is essential for BMP7-mediated retinal reactive gliosis. J Neuroinflammation. 2017; 14(1):76. PMC: 5382432. DOI: 10.1186/s12974-017-0855-0. View